SMTL ID : 3oct.1

Crystal structure of bruton's tyrosine kinase mutant V555R in complex with dasatinib

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.95 Å

Oligo State

monomer

Ligands

1 x 1N1: N-(2-CHLORO-6-METHYLPHENYL)-2-({6-[4-(2-HYDROXYETHYL)PIPERAZIN-1-YL]-2-METHYLPYRIMIDIN-4-YL}AMINO)-1,3-THIAZOLE-5-CARBOXAMIDE(Non-covalent)

1N1.1: 19 residues within 4Å: Chain A: L.17, F.22, V.25, A.37, K.39, M.58, V.67, I.81, T.83, E.84, Y.85, M.86, A.87, N.88, G.89, E.97, L.137, S.147, F.149 12 PLIP interactions: 12 interactions with chain A Hydrophobic interactions: A:A.37, A:K.39, A:K.39, A:I.81, A:T.83, A:Y.85, A:F.149 Hydrogen bonds: A:T.83, A:T.83, A:M.86, A:M.86, A:N.88

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Di Paolo, J.A. et al., A novel, specific Btk inhibitor antagonizes BCR and Fc[gamma]R signaling and suppresses inflammatory arthritis. To be Published

Release Date

2010-11-03

Peptides

Tyrosine-protein kinase BTK: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Tyrosine-protein kinase BTK